PRCT vs. NVO
Compare and contrast key facts about PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRCT or NVO.
Key characteristics
| PRCT | NVO | |
|---|---|---|
| YTD Return | 127.99% | 4.63% |
| 1Y Return | 197.66% | 7.40% |
| 3Y Return (Ann) | 32.34% | 25.41% |
| Sharpe Ratio | 3.30 | 0.23 |
| Sortino Ratio | 4.82 | 0.56 |
| Omega Ratio | 1.55 | 1.07 |
| Calmar Ratio | 5.69 | 0.25 |
| Martin Ratio | 28.19 | 0.71 |
| Ulcer Index | 7.39% | 9.75% |
| Daily Std Dev | 63.07% | 30.26% |
| Max Drawdown | -63.51% | -71.30% |
| Current Drawdown | -3.55% | -26.85% |
Fundamentals
| PRCT | NVO | |
|---|---|---|
| Market Cap | $5.17B | $494.05B |
| EPS | -$1.95 | $3.03 |
| Total Revenue (TTM) | $199.84M | $199.27B |
| Gross Profit (TTM) | $112.10M | $169.07B |
| EBITDA (TTM) | -$98.77M | $98.21B |
Correlation
The correlation between PRCT and NVO is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PRCT vs. NVO - Performance Comparison
In the year-to-date period, PRCT achieves a 127.99% return, which is significantly higher than NVO's 4.63% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PRCT vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRCT vs. NVO - Dividend Comparison
PRCT has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.35%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRCT PROCEPT BioRobotics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 1.35% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% | 1.72% |
Drawdowns
PRCT vs. NVO - Drawdown Comparison
The maximum PRCT drawdown since its inception was -63.51%, smaller than the maximum NVO drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for PRCT and NVO. For additional features, visit the drawdowns tool.
Volatility
PRCT vs. NVO - Volatility Comparison
PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 30.92% compared to Novo Nordisk A/S (NVO) at 6.44%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PRCT vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities